Butensky & Cohen Financial Security Inc. Sells 7,871 Shares of CVS Health Co. (NYSE:CVS)

Butensky & Cohen Financial Security Inc. cut its stake in shares of CVS Health Co. (NYSE:CVS) by 14.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,910 shares of the pharmacy operator’s stock after selling 7,871 shares during the period. Butensky & Cohen Financial Security Inc.’s holdings in CVS Health were worth $2,151,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health during the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health during the third quarter worth $31,000. Legacy Investment Solutions LLC purchased a new position in CVS Health in the third quarter worth $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the 3rd quarter valued at $32,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health during the 3rd quarter worth $33,000. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on CVS shares. Mizuho decreased their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Royal Bank of Canada lowered their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research note on Friday, November 15th. StockNews.com downgraded CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Cantor Fitzgerald reaffirmed a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a report on Tuesday, October 1st. Finally, UBS Group lifted their target price on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Trading Up 1.5 %

Shares of CVS opened at $52.72 on Friday. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a market capitalization of $66.35 billion, a P/E ratio of 13.38, a P/E/G ratio of 0.72 and a beta of 0.59. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm’s 50 day simple moving average is $51.39 and its 200 day simple moving average is $56.36.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm’s revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.21 EPS. Sell-side analysts forecast that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Investors of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.05%. CVS Health’s dividend payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.